Summary
According to APO Research, The global Anti-allergic Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Anti-allergic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Anti-allergic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Anti-allergic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Anti-allergic Drugs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Anti-allergic Drugs include Sanofi, Johnson And Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Sun Pharma, UCB Pharma and Yangtze River Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Anti-allergic Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Anti-allergic Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Anti-allergic Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-allergic Drugs revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Anti-allergic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Anti-allergic Drugs revenue, projected growth trends, production technology, application and end-user industry.
Anti-allergic Drugs segment by Company
Sanofi
Johnson And Johnson
Merck
Teva
GlaxoSmithKline
Bayer
Sun Pharma
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays
Anti-allergic Drugs segment by Type
Oral Drugs
Non-Oral Drugs
Anti-allergic Drugs segment by Sales Channel
Online
Offline
Anti-allergic Drugs segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-allergic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-allergic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-allergic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Anti-allergic Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Anti-allergic Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-allergic Drugs revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Anti-allergic Drugs Market by Type
1.2.1 Global Anti-allergic Drugs Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Oral Drugs
1.2.3 Non-Oral Drugs
1.3 Anti-allergic Drugs Market by Sales Channel
1.3.1 Global Anti-allergic Drugs Market Size by Sales Channel, 2019 VS 2023 VS 2030
1.3.2 Online
1.3.3 Offline
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Anti-allergic Drugs Market Dynamics
2.1 Anti-allergic Drugs Industry Trends
2.2 Anti-allergic Drugs Industry Drivers
2.3 Anti-allergic Drugs Industry Opportunities and Challenges
2.4 Anti-allergic Drugs Industry Restraints
3 Global Growth Perspective
3.1 Global Anti-allergic Drugs Market Perspective (2019-2030)
3.2 Global Anti-allergic Drugs Growth Trends by Region
3.2.1 Global Anti-allergic Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Anti-allergic Drugs Market Size by Region (2019-2024)
3.2.3 Global Anti-allergic Drugs Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Anti-allergic Drugs Revenue by Players
4.1.1 Global Anti-allergic Drugs Revenue by Players (2019-2024)
4.1.2 Global Anti-allergic Drugs Revenue Market Share by Players (2019-2024)
4.1.3 Global Anti-allergic Drugs Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Anti-allergic Drugs Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Anti-allergic Drugs Key Players Headquarters & Area Served
4.4 Global Anti-allergic Drugs Players, Product Type & Application
4.5 Global Anti-allergic Drugs Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Anti-allergic Drugs Market CR5 and HHI
4.6.2 Global Top 5 and 10 Anti-allergic Drugs Players Market Share by Revenue in 2023
4.6.3 2023 Anti-allergic Drugs Tier 1, Tier 2, and Tier 3
5 Anti-allergic Drugs Market Size by Type
5.1 Global Anti-allergic Drugs Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Anti-allergic Drugs Revenue by Type (2019-2030)
5.3 Global Anti-allergic Drugs Revenue Market Share by Type (2019-2030)
6 Anti-allergic Drugs Market Size by Application
6.1 Global Anti-allergic Drugs Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Anti-allergic Drugs Revenue by Application (2019-2030)
6.3 Global Anti-allergic Drugs Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Comapny Information
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Anti-allergic Drugs Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi Anti-allergic Drugs Product Portfolio
7.1.5 Sanofi Recent Developments
7.2 Johnson And Johnson
7.2.1 Johnson And Johnson Comapny Information
7.2.2 Johnson And Johnson Business Overview
7.2.3 Johnson And Johnson Anti-allergic Drugs Revenue and Gross Margin (2019-2024)
7.2.4 Johnson And Johnson Anti-allergic Drugs Product Portfolio
7.2.5 Johnson And Johnson Recent Developments
7.3 Merck
7.3.1 Merck Comapny Information
7.3.2 Merck Business Overview
7.3.3 Merck Anti-allergic Drugs Revenue and Gross Margin (2019-2024)
7.3.4 Merck Anti-allergic Drugs Product Portfolio
7.3.5 Merck Recent Developments
7.4 Teva
7.4.1 Teva Comapny Information
7.4.2 Teva Business Overview
7.4.3 Teva Anti-allergic Drugs Revenue and Gross Margin (2019-2024)
7.4.4 Teva Anti-allergic Drugs Product Portfolio
7.4.5 Teva Recent Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Comapny Information
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Anti-allergic Drugs Revenue and Gross Margin (2019-2024)
7.5.4 GlaxoSmithKline Anti-allergic Drugs Product Portfolio
7.5.5 GlaxoSmithKline Recent Developments
7.6 Bayer
7.6.1 Bayer Comapny Information
7.6.2 Bayer Business Overview
7.6.3 Bayer Anti-allergic Drugs Revenue and Gross Margin (2019-2024)
7.6.4 Bayer Anti-allergic Drugs Product Portfolio
7.6.5 Bayer Recent Developments
7.7 Sun Pharma
7.7.1 Sun Pharma Comapny Information
7.7.2 Sun Pharma Business Overview
7.7.3 Sun Pharma Anti-allergic Drugs Revenue and Gross Margin (2019-2024)
7.7.4 Sun Pharma Anti-allergic Drugs Product Portfolio
7.7.5 Sun Pharma Recent Developments
7.8 UCB Pharma
7.8.1 UCB Pharma Comapny Information
7.8.2 UCB Pharma Business Overview
7.8.3 UCB Pharma Anti-allergic Drugs Revenue and Gross Margin (2019-2024)
7.8.4 UCB Pharma Anti-allergic Drugs Product Portfolio
7.8.5 UCB Pharma Recent Developments
7.9 Yangtze River Pharmaceutical Group
7.9.1 Yangtze River Pharmaceutical Group Comapny Information
7.9.2 Yangtze River Pharmaceutical Group Business Overview
7.9.3 Yangtze River Pharmaceutical Group Anti-allergic Drugs Revenue and Gross Margin (2019-2024)
7.9.4 Yangtze River Pharmaceutical Group Anti-allergic Drugs Product Portfolio
7.9.5 Yangtze River Pharmaceutical Group Recent Developments
7.10 Hainan Poly Pharm
7.10.1 Hainan Poly Pharm Comapny Information
7.10.2 Hainan Poly Pharm Business Overview
7.10.3 Hainan Poly Pharm Anti-allergic Drugs Revenue and Gross Margin (2019-2024)
7.10.4 Hainan Poly Pharm Anti-allergic Drugs Product Portfolio
7.10.5 Hainan Poly Pharm Recent Developments
7.11 Chongqing Huapont Pharmaceutical
7.11.1 Chongqing Huapont Pharmaceutical Comapny Information
7.11.2 Chongqing Huapont Pharmaceutical Business Overview
7.11.3 Chongqing Huapont Pharmaceutical Anti-allergic Drugs Revenue and Gross Margin (2019-2024)
7.11.4 Chongqing Huapont Pharmaceutical Anti-allergic Drugs Product Portfolio
7.11.5 Chongqing Huapont Pharmaceutical Recent Developments
7.12 Dawnrays
7.12.1 Dawnrays Comapny Information
7.12.2 Dawnrays Business Overview
7.12.3 Dawnrays Anti-allergic Drugs Revenue and Gross Margin (2019-2024)
7.12.4 Dawnrays Anti-allergic Drugs Product Portfolio
7.12.5 Dawnrays Recent Developments
8 North America
8.1 North America Anti-allergic Drugs Revenue (2019-2030)
8.2 North America Anti-allergic Drugs Revenue by Type (2019-2030)
8.2.1 North America Anti-allergic Drugs Revenue by Type (2019-2024)
8.2.2 North America Anti-allergic Drugs Revenue by Type (2025-2030)
8.3 North America Anti-allergic Drugs Revenue Share by Type (2019-2030)
8.4 North America Anti-allergic Drugs Revenue by Sales Channel (2019-2030)
8.4.1 North America Anti-allergic Drugs Revenue by Sales Channel (2019-2024)
8.4.2 North America Anti-allergic Drugs Revenue by Sales Channel (2025-2030)
8.5 North America Anti-allergic Drugs Revenue Share by Sales Channel (2019-2030)
8.6 North America Anti-allergic Drugs Revenue by Country
8.6.1 North America Anti-allergic Drugs Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Anti-allergic Drugs Revenue by Country (2019-2024)
8.6.3 North America Anti-allergic Drugs Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Anti-allergic Drugs Revenue (2019-2030)
9.2 Europe Anti-allergic Drugs Revenue by Type (2019-2030)
9.2.1 Europe Anti-allergic Drugs Revenue by Type (2019-2024)
9.2.2 Europe Anti-allergic Drugs Revenue by Type (2025-2030)
9.3 Europe Anti-allergic Drugs Revenue Share by Type (2019-2030)
9.4 Europe Anti-allergic Drugs Revenue by Sales Channel (2019-2030)
9.4.1 Europe Anti-allergic Drugs Revenue by Sales Channel (2019-2024)
9.4.2 Europe Anti-allergic Drugs Revenue by Sales Channel (2025-2030)
9.5 Europe Anti-allergic Drugs Revenue Share by Sales Channel (2019-2030)
9.6 Europe Anti-allergic Drugs Revenue by Country
9.6.1 Europe Anti-allergic Drugs Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Anti-allergic Drugs Revenue by Country (2019-2024)
9.6.3 Europe Anti-allergic Drugs Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Anti-allergic Drugs Revenue (2019-2030)
10.2 China Anti-allergic Drugs Revenue by Type (2019-2030)
10.2.1 China Anti-allergic Drugs Revenue by Type (2019-2024)
10.2.2 China Anti-allergic Drugs Revenue by Type (2025-2030)
10.3 China Anti-allergic Drugs Revenue Share by Type (2019-2030)
10.4 China Anti-allergic Drugs Revenue by Sales Channel (2019-2030)
10.4.1 China Anti-allergic Drugs Revenue by Sales Channel (2019-2024)
10.4.2 China Anti-allergic Drugs Revenue by Sales Channel (2025-2030)
10.5 China Anti-allergic Drugs Revenue Share by Sales Channel (2019-2030)
11 Asia (Excluding China)
11.1 Asia Anti-allergic Drugs Revenue (2019-2030)
11.2 Asia Anti-allergic Drugs Revenue by Type (2019-2030)
11.2.1 Asia Anti-allergic Drugs Revenue by Type (2019-2024)
11.2.2 Asia Anti-allergic Drugs Revenue by Type (2025-2030)
11.3 Asia Anti-allergic Drugs Revenue Share by Type (2019-2030)
11.4 Asia Anti-allergic Drugs Revenue by Sales Channel (2019-2030)
11.4.1 Asia Anti-allergic Drugs Revenue by Sales Channel (2019-2024)
11.4.2 Asia Anti-allergic Drugs Revenue by Sales Channel (2025-2030)
11.5 Asia Anti-allergic Drugs Revenue Share by Sales Channel (2019-2030)
11.6 Asia Anti-allergic Drugs Revenue by Country
11.6.1 Asia Anti-allergic Drugs Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Anti-allergic Drugs Revenue by Country (2019-2024)
11.6.3 Asia Anti-allergic Drugs Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Anti-allergic Drugs Revenue (2019-2030)
12.2 MEALA Anti-allergic Drugs Revenue by Type (2019-2030)
12.2.1 MEALA Anti-allergic Drugs Revenue by Type (2019-2024)
12.2.2 MEALA Anti-allergic Drugs Revenue by Type (2025-2030)
12.3 MEALA Anti-allergic Drugs Revenue Share by Type (2019-2030)
12.4 MEALA Anti-allergic Drugs Revenue by Sales Channel (2019-2030)
12.4.1 MEALA Anti-allergic Drugs Revenue by Sales Channel (2019-2024)
12.4.2 MEALA Anti-allergic Drugs Revenue by Sales Channel (2025-2030)
12.5 MEALA Anti-allergic Drugs Revenue Share by Sales Channel (2019-2030)
12.6 MEALA Anti-allergic Drugs Revenue by Country
12.6.1 MEALA Anti-allergic Drugs Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Anti-allergic Drugs Revenue by Country (2019-2024)
12.6.3 MEALA Anti-allergic Drugs Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Anti-allergic Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Oral Drugs Major Manufacturers
Table 2. Non-Oral Drugs Major Manufacturers
Table 3. Global Anti-allergic Drugs Market Size Growth Rate by Sales Channel (US$ Million), 2019 VS 2023 VS 2030
Table 4. Online Major Manufacturers
Table 5. Offline Major Manufacturers
Table 6. Anti-allergic Drugs Industry Trends
Table 7. Anti-allergic Drugs Industry Drivers
Table 8. Anti-allergic Drugs Industry Opportunities and Challenges
Table 9. Anti-allergic Drugs Industry Restraints
Table 10. Global Anti-allergic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Anti-allergic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Anti-allergic Drugs Market Share by Region (2019-2024)
Table 13. Global Anti-allergic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Anti-allergic Drugs Market Share by Region (2025-2030)
Table 15. Global Anti-allergic Drugs Revenue by Players (US$ Million) & (2019-2024)
Table 16. Global Anti-allergic Drugs Revenue Market Share by Players (2019-2024)
Table 17. Global Anti-allergic Drugs Key Players Ranking, 2022 VS 2023 VS 2024
Table 18. Global Anti-allergic Drugs Key Players Headquarters & Area Served
Table 19. Global Anti-allergic Drugs Players, Product Type & Application
Table 20. Global Anti-allergic Drugs Players Commercialization Time
Table 21. Global Players Market Concentration Ratio (CR5 and HHI)
Table 22. Global Anti-allergic Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 23. Global Anti-allergic Drugs Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Anti-allergic Drugs Revenue by Type (2019-2024) & (US$ Million)
Table 25. Global Anti-allergic Drugs Revenue by Type (2025-2030) & (US$ Million)
Table 26. Global Anti-allergic Drugs Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 27. Global Anti-allergic Drugs Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 28. Global Anti-allergic Drugs Revenue by Sales Channel 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Anti-allergic Drugs Revenue by Sales Channel (2019-2024) & (US$ Million)
Table 30. Global Anti-allergic Drugs Revenue by Sales Channel (2025-2030) & (US$ Million)
Table 31. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2019-2024) & (US$ Million)
Table 32. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2025-2030) & (US$ Million)
Table 33. Sanofi Company Information
Table 34. Sanofi Business Overview
Table 35. Sanofi Anti-allergic Drugs Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 36. Sanofi Anti-allergic Drugs Product Portfolio
Table 37. Sanofi Recent Development
Table 38. Johnson And Johnson Company Information
Table 39. Johnson And Johnson Business Overview
Table 40. Johnson And Johnson Anti-allergic Drugs Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 41. Johnson And Johnson Anti-allergic Drugs Product Portfolio
Table 42. Johnson And Johnson Recent Development
Table 43. Merck Company Information
Table 44. Merck Business Overview
Table 45. Merck Anti-allergic Drugs Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 46. Merck Anti-allergic Drugs Product Portfolio
Table 47. Merck Recent Development
Table 48. Teva Company Information
Table 49. Teva Business Overview
Table 50. Teva Anti-allergic Drugs Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 51. Teva Anti-allergic Drugs Product Portfolio
Table 52. Teva Recent Development
Table 53. GlaxoSmithKline Company Information
Table 54. GlaxoSmithKline Business Overview
Table 55. GlaxoSmithKline Anti-allergic Drugs Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 56. GlaxoSmithKline Anti-allergic Drugs Product Portfolio
Table 57. GlaxoSmithKline Recent Development
Table 58. Bayer Company Information
Table 59. Bayer Business Overview
Table 60. Bayer Anti-allergic Drugs Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 61. Bayer Anti-allergic Drugs Product Portfolio
Table 62. Bayer Recent Development
Table 63. Sun Pharma Company Information
Table 64. Sun Pharma Business Overview
Table 65. Sun Pharma Anti-allergic Drugs Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 66. Sun Pharma Anti-allergic Drugs Product Portfolio
Table 67. Sun Pharma Recent Development
Table 68. UCB Pharma Company Information
Table 69. UCB Pharma Business Overview
Table 70. UCB Pharma Anti-allergic Drugs Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 71. UCB Pharma Anti-allergic Drugs Product Portfolio
Table 72. UCB Pharma Recent Development
Table 73. Yangtze River Pharmaceutical Group Company Information
Table 74. Yangtze River Pharmaceutical Group Business Overview
Table 75. Yangtze River Pharmaceutical Group Anti-allergic Drugs Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 76. Yangtze River Pharmaceutical Group Anti-allergic Drugs Product Portfolio
Table 77. Yangtze River Pharmaceutical Group Recent Development
Table 78. Hainan Poly Pharm Company Information
Table 79. Hainan Poly Pharm Business Overview
Table 80. Hainan Poly Pharm Anti-allergic Drugs Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 81. Hainan Poly Pharm Anti-allergic Drugs Product Portfolio
Table 82. Hainan Poly Pharm Recent Development
Table 83. Chongqing Huapont Pharmaceutical Company Information
Table 84. Chongqing Huapont Pharmaceutical Business Overview
Table 85. Chongqing Huapont Pharmaceutical Anti-allergic Drugs Sales (), Revenue (US$ Million), Price () and Gross Margin (2019-2024)
Table 86. Chongqing Huapont Pharmaceutical Anti-allergic Drugs Product Portfolio
Table 87. Chongqing Huapont Pharmaceutical Recent Development
Table 88. Dawnrays Company Information
Table 89. Dawnrays Business Overview
Table 90. Dawnrays Anti-allergic Drugs Sales (), Revenue (US$ Million), Price () and Gross Margin (2019-2024)
Table 91. Dawnrays Anti-allergic Drugs Product Portfolio
Table 92. Dawnrays Recent Development
Table 93. North America Anti-allergic Drugs Revenue by Type (2019-2024) & (US$ Million)
Table 94. North America Anti-allergic Drugs Revenue by Sales Channel (2019-2024) & (US$ Million)
Table 95. North America Anti-allergic Drugs Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 96. North America Anti-allergic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 97. North America Anti-allergic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 98. Europe Anti-allergic Drugs Revenue by Type (2019-2024) & (US$ Million)
Table 99. Europe Anti-allergic Drugs Revenue by Sales Channel (2019-2024) & (US$ Million)
Table 100. Europe Anti-allergic Drugs Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 101. Europe Anti-allergic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 102. Europe Anti-allergic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 103. China Anti-allergic Drugs Revenue by Type (2019-2024) & (US$ Million)
Table 104. China Anti-allergic Drugs Revenue by Sales Channel (2019-2024) & (US$ Million)
Table 105. Asia Anti-allergic Drugs Revenue by Type (2019-2024) & (US$ Million)
Table 106. Asia Anti-allergic Drugs Revenue by Sales Channel (2019-2024) & (US$ Million)
Table 107. Asia Anti-allergic Drugs Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 108. Asia Anti-allergic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 109. Asia Anti-allergic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 110. MEALA Anti-allergic Drugs Revenue by Type (2019-2024) & (US$ Million)
Table 111. MEALA Anti-allergic Drugs Revenue by Sales Channel (2019-2024) & (US$ Million)
Table 112. MEALA Anti-allergic Drugs Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 113. MEALA Anti-allergic Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 114. MEALA Anti-allergic Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 115. Research Programs/Design for This Report
Table 116. Authors List of This Report
Table 117. Secondary Sources
Table 118. Primary Sources
List of Figures
Figure 1. Anti-allergic Drugs Product Picture
Figure 2. Global Anti-allergic Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Anti-allergic Drugs Market Size Share 2019 VS 2023 VS 2030
Figure 4. Oral Drugs Picture
Figure 5. Non-Oral Drugs Picture
Figure 6. Global Anti-allergic Drugs Market Size Growth Rate by Sales Channel (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Anti-allergic Drugs Market Size Share 2019 VS 2023 VS 2030
Figure 8. Online Picture
Figure 9. Offline Picture
Figure 10. Global Anti-allergic Drugs Market Size (US$ Million) & (2019-2030)
Figure 11. Global Anti-allergic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Anti-allergic Drugs Market Share by Region: 2019 VS 2023 VS 2030
Figure 13. Global Anti-allergic Drugs Players Revenue Share Top 10 and Top 5 in 2023
Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 15. Global Anti-allergic Drugs Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Anti-allergic Drugs Revenue Market Share 2019 VS 2023 VS 2030
Figure 17. Global Anti-allergic Drugs Revenue Market Share by Type (2019-2030)
Figure 18. Global Anti-allergic Drugs Revenue by Sales Channel (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2019 VS 2023 VS 2030)
Figure 20. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2019-2030)
Figure 21. North America Anti-allergic Drugs Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Anti-allergic Drugs Revenue by Type (2025-2030) & (US$ Million)
Figure 23. North America Anti-allergic Drugs Revenue Share by Type (2019-2030)
Figure 24. North America Anti-allergic Drugs Revenue by Application (2025-2030) & (US$ Million)
Figure 25. North America Anti-allergic Drugs Revenue Share by Application (2019-2030)
Figure 26. North America Anti-allergic Drugs Revenue Share by Country (2019-2030)
Figure 27. United States Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 28. Canada Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Europe Anti-allergic Drugs Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Anti-allergic Drugs Revenue by Type (2025-2030) & (US$ Million)
Figure 31. Europe Anti-allergic Drugs Revenue Share by Type (2019-2030)
Figure 32. Europe Anti-allergic Drugs Revenue by Application (2025-2030) & (US$ Million)
Figure 33. Europe Anti-allergic Drugs Revenue Share by Application (2019-2030)
Figure 34. Europe Anti-allergic Drugs Revenue Share by Country (2019-2030)
Figure 35. Germany Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 36. France Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. U.K. Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. Italy Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Russia Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Nordic Countries Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. China Anti-allergic Drugs Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Anti-allergic Drugs Revenue by Type (2025-2030) & (US$ Million)
Figure 43. China Anti-allergic Drugs Revenue Share by Type (2019-2030)
Figure 44. China Anti-allergic Drugs Revenue by Application (2025-2030) & (US$ Million)
Figure 45. China Anti-allergic Drugs Revenue Share by Application (2019-2030)
Figure 46. Asia Anti-allergic Drugs Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 47. Asia Anti-allergic Drugs Revenue by Type (2025-2030) & (US$ Million)
Figure 48. Asia Anti-allergic Drugs Revenue Share by Type (2019-2030)
Figure 49. Asia Anti-allergic Drugs Revenue by Application (2025-2030) & (US$ Million)
Figure 50. Asia Anti-allergic Drugs Revenue Share by Application (2019-2030)
Figure 51. Asia Anti-allergic Drugs Revenue Share by Country (2019-2030)
Figure 52. Japan Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 53. South Korea Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. India Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. Australia Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. China Taiwan Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. Southeast Asia Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. MEALA Anti-allergic Drugs Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 59. MEALA Anti-allergic Drugs Revenue by Type (2025-2030) & (US$ Million)
Figure 60. MEALA Anti-allergic Drugs Revenue Share by Type (2019-2030)
Figure 61. MEALA Anti-allergic Drugs Revenue by Application (2025-2030) & (US$ Million)
Figure 62. MEALA Anti-allergic Drugs Revenue Share by Application (2019-2030)
Figure 63. MEALA Anti-allergic Drugs Revenue Share by Country (2019-2030)
Figure 64. Mexico Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 65. South Korea Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. Brazil Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Israel Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Argentina Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Colombia Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Turkey Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Saudi Arabia Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. UAE Anti-allergic Drugs Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Years Considered
Figure 74. Research Process
Figure 75. Key Executives Interviewed
